ICM
IAS

Invenomic Capital Management’s Integral Ad Science IAS Stock Holding History

Invenomic Capital Management’s Portfolio IAS Stock Details IAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,580,066
Closed -$13.1M – 158
2025
Q2 		$13.1M Sell
1,580,066
-69,917
-4% -$533K 0.75% 47
2025
Q1 		$13.3M Buy
1,649,983
+754,922
+84% +$7.53M 0.67% 55
2024
Q4 		$9.34M Buy
895,061
+309,752
+53% +$3.4M 0.44% 75
2024
Q3 		$6.33M Buy
585,309
+213,488
+57% +$2.29M 0.35% 84
2024
Q2 		$3.61M Buy
+371,821
New +$3.56M 0.18% 118

Other funds holding IAS

VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Invenomic Capital Management's IAS Position: Q3 2025 in Review

Invenomic Capital Management sold out of Integral Ad Science (IAS) in Q3 2025, closing a stake of 1,580,066 shares — an estimated $13.1M sold.

Invenomic Capital Management first reported a position in IAS in Q2 2024 and held it in 5 quarters. The position peaked at $13.3M in Q1 2025. 171 funds tracked by Wall St. Rank hold IAS as of Q3 2025.

  • Invenomic Capital Management reported no remaining Integral Ad Science position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 1,580,066 Integral Ad Science shares in Q3 2025, an estimated $13.1M.
  • Invenomic Capital Management first reported a position in Integral Ad Science in Q2 2024 and held it in 5 quarters.
  • Invenomic Capital Management's Integral Ad Science position peaked at $13.3M in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Integral Ad Science as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.